TALPHERA, INC. Lease, Cost
TALPHERA, INC. (TLPH) reported Lease, Cost of $200.00 thousand for the 12-month period ending 2022-12-31, per its 8-K filed 2023-08-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2023-08-01
- TALPHERA, INC. lease, cost for the quarter ending 2021-12-31 was -$586.00K, a 297.31% decline year-over-year.
- TALPHERA, INC. lease, cost for the quarter ending 2021-09-30 was $343.00K, a 121.29% increase year-over-year.
- TALPHERA, INC. lease, cost for the quarter ending 2020-12-31 was $297.00K, a 56.32% increase year-over-year.
- TALPHERA, INC. lease, cost for the quarter ending 2020-09-30 was $155.00K, a 18.42% decline year-over-year.
- TALPHERA, INC. lease, cost for fiscal 2020 was $762.00K, a 0.26% decline from fiscal 2019.
- TALPHERA, INC. lease, cost for fiscal 2019 was $764.00K.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month | Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $200.00K 8-K · filed 2023-08-01 | $1.37M 10-K · filed 2023-03-31 | |||
| 2021-12-31 | -$586.00K derived: 8-K 12 month − 10-Q 9 month · filed 2023-08-01 | -$243.00K derived: sum of 2 quarters · filed 2023-08-01 | $147.00K 8-K · filed 2023-08-01 | $1.08M 10-K · filed 2022-03-10 | |
| 2021-09-30 | $343.00K 10-Q · filed 2021-11-15 | $733.00K 10-Q · filed 2021-11-15 | |||
| 2020-12-31 | $297.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $452.00K derived: sum of 2 quarters · filed 2022-03-10 | $572.00K derived: sum of 3 quarters · filed 2022-03-10 | $762.00K 10-K · filed 2022-03-10 | |
| 2020-09-30 | $155.00K 10-Q · filed 2021-11-15 | $275.00K derived: sum of 2 quarters · filed 2021-11-15 | $465.00K 10-Q · filed 2021-11-15 | $655.00K derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $120.00K 10-Q · filed 2020-08-10 | $310.00K 10-Q · filed 2020-08-10 | $500.00K derived: sum of 3 quarters · filed 2021-03-15 | $690.00K derived: sum of 4 quarters · filed 2021-03-15 | |
| 2020-03-31 | $190.00K 10-Q · filed 2020-05-11 | $380.00K derived: sum of 2 quarters · filed 2021-03-15 | $570.00K derived: sum of 3 quarters · filed 2021-03-15 | $760.00K derived: sum of 4 quarters · filed 2021-03-15 | |
| 2019-12-31 | $190.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $380.00K derived: sum of 2 quarters · filed 2021-03-15 | $570.00K derived: sum of 3 quarters · filed 2021-03-15 | $764.00K 10-K · filed 2021-03-15 | |
| 2019-09-30 | $190.00K 10-Q · filed 2020-11-05 | $380.00K derived: sum of 2 quarters · filed 2020-11-05 | $574.00K 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $190.00K 10-Q · filed 2020-08-10 | $384.00K 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | $194.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |